Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabil Baba-Hamed

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|April 16, 2019
[Canal anal carcinoma]Nabil Baba-Hamed, Alix Portal
Cureus|August 27, 2021
Posterior Reversible Encephalopathy Occurring During Treatment With PalbociclibLahcene Belaidi, Nabil Baba-Hamed, Francesco Savinelli, et al.
BMC Cancer|July 6, 2016
Cetuximab-induced aseptic meningitis: case report and review of a rare adverse eventChristophe Maritaz, Carole Metz, Nabil Baba-Hamed, et al.
Molecular Diagnosis & Therapy|January 24, 2024
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics AdvancesSoledad Iseas, Golubicki Mariano, Louis Gros, et al.
Biomedicines|March 29, 2023
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric CohortSoledad Iseas, Diego Prost, Sarah Bouchereau, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 19, 2021
What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohortManon Bacci, Laurent Quero, Emilie Barbier, et al.
British Journal of Cancer|January 6, 2024
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASEClaire Gouriou, Claire Lemanski, Pascal Pommier, et al.
International Journal of Oncology|February 6, 2019
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II studyBenoist Chibaudel, Jean-Baptiste Bachet, Thierry André, et al.
Signal Transduction and Targeted Therapy|April 14, 2026
STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancerBenoist Chibaudel, Louis-Marie Dourthe, Thierry André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 TrialAlice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|April 16, 2019
[Canal anal carcinoma]Nabil Baba-Hamed, Alix Portal
Cureus|August 27, 2021
Posterior Reversible Encephalopathy Occurring During Treatment With PalbociclibLahcene Belaidi, Nabil Baba-Hamed, Francesco Savinelli, et al.
BMC Cancer|July 6, 2016
Cetuximab-induced aseptic meningitis: case report and review of a rare adverse eventChristophe Maritaz, Carole Metz, Nabil Baba-Hamed, et al.
Molecular Diagnosis & Therapy|January 24, 2024
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics AdvancesSoledad Iseas, Golubicki Mariano, Louis Gros, et al.
Biomedicines|March 29, 2023
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric CohortSoledad Iseas, Diego Prost, Sarah Bouchereau, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 19, 2021
What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohortManon Bacci, Laurent Quero, Emilie Barbier, et al.
British Journal of Cancer|January 6, 2024
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASEClaire Gouriou, Claire Lemanski, Pascal Pommier, et al.
International Journal of Oncology|February 6, 2019
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II studyBenoist Chibaudel, Jean-Baptiste Bachet, Thierry André, et al.
Signal Transduction and Targeted Therapy|April 14, 2026
STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancerBenoist Chibaudel, Louis-Marie Dourthe, Thierry André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 TrialAlice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Pageof 2